Notably, recent population studies have shown that IGF-1 levels are lower when individuals suffer from conditions such as obesity (31), lipid metabolism disorders (32), hypertension (33), and metabolic syndrome (34). This evidence concerns the gene IGF1 and obesity due to melanocortin 4 receptor deficiency.